Lucie Mondoulet - DBV Technologies Director of Research Department

Director

Ms. Lucie Mondoulet is the Director of Research of DBV Technologies SA. She graduated in Biochemical and Food Engineering from Institut National des Sciences Appliquees in Toulouse and then specialized in the field of food allergy. She graduated with a Doctorate degree from INRA in the immunology and food allergy unit, where she studied the biochemical composition of peanut allergens and related treatments. She then specialized with postdoctorate research at the CNRS in Paris within the allergy and environment department, where she was in charge of pollen allergens purification and studied the immunologic response of allergic patients. She then joined DBV Technologies SA as a Research Engineer and first set up preclinical models in the field of pharmacology before taking charge of the coordination of the research team.
Phone33 1 55 42 78 78
Webhttps://www.dbv-technologies.com

DBV Technologies Management Efficiency

The company has return on total asset (ROA) of (31.96) % which means that it has lost $31.96 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (67.72) %, meaning that it generated substantial loss on money invested by shareholders. DBV Technologies' management efficiency ratios could be used to measure how well DBV Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 4.63 M in total debt with debt to equity ratio (D/E) of 0.06, which may suggest the company is not taking enough advantage from borrowing. DBV Technologies has a current ratio of 3.4, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist DBV Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, DBV Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DBV Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DBV to invest in growth at high rates of return. When we think about DBV Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Candace DuncanTeleflex Incorporated
67
Chang ChanIntegrated Media Technology
50
Moshe ShohamMicrobot Medical
64
Gretchen HaggertyTeleflex Incorporated
65
Jeffrey GravesTeleflex Incorporated
55
ManChung ChanIntegrated Media Technology
55
Kim FosterTeleflex Incorporated
68
Alvin KrongardIridium Communications
81
Stuart RandleTeleflex Incorporated
61
Jane HarmanIridium Communications
72
Eric OlsonIridium Communications
66
Andrew KrakauerTeleflex Incorporated
66
Stephen KlaskoTeleflex Incorporated
67
Steven PfeifferIridium Communications
71
Stanford SmithIridium Communications
55
Prattipati LaxminarainMicrobot Medical
59
Yoav WaizerMicrobot Medical
51
Patricia BarronTeleflex Incorporated
73
Timothy IngramIntegrated Media Technology
N/A
Richard PackerTeleflex Incorporated
62
Con UnerkovIntegrated Media Technology
55
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France. Dbv Technologies is traded on OTC Exchange in the United States. DBV Technologies SA [DBVTF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

DBV Technologies Leadership Team

Elected by the shareholders, the DBV Technologies' board of directors comprises two types of representatives: DBV Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DBV. The board's role is to monitor DBV Technologies' management team and ensure that shareholders' interests are well served. DBV Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DBV Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Pascale Ehouarn, Industrial Development and Production Director
Claude Thebault, Medical Director
Wence Agbotounou, Chief Clinical Trial Officer
Laurent Martin, Director of Regulatory Affairs
Viviane Monges, Director
Didier Hoch, Director
Hugh Sampson, Chief Scientific Officer
Charles Ruban, Chief Development Officer
Nathalie Donne, Director of Bus. Devel. and Corporate Communication
Lucie Mondoulet, Director of Research Department
Chahra Louafi, Director - Representative of CDC Entreprises (Innobio)
Peter Hutt, Independent Director
Rafaele Tordjman, Director - Representative of Sofinnova Partners
Bertrand Dupont, Co-Founder and Sr. Executive VP of Technology
Veronique Foutel, Director of Strategic Marketing
FAAAAI MD, Chief Scientific Officer, Advisor and Member of The Scientific Advisory Board
Daniel Tasse, CEO, Director
Rafale Tordjman, Director - Representative of Sofinnova Partners
Joan Schmidt, Executive Vice President General Counsel
George Horner, Director
Torbjorn Bjerke, Independent Director
Pharis Mohideen, Chief Medical Officer
PierreHenri Benhamou, Chairman of the Board, CEO
Torbjrn Bjerke, Independent Director
Mailys Ferrere, Director
Michel Rosen, Director
David Schilansky, COO

DBV Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is DBV Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with DBV Technologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DBV Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DBV Technologies will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Whirlpool could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Whirlpool when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Whirlpool - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Whirlpool to buy it.
The correlation of Whirlpool is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Whirlpool moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Whirlpool moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Whirlpool can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in DBV OTC Stock

If you are still planning to invest in DBV Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DBV Technologies' history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments